Never Run Out Of Buyers To Sell To.
ARTMS specializes in the physics, chemistry and materials science of cyclotron-produced radionuclides. Our core technology platform, the QUANTM Irradiation System™ (QIS™), is a complete cyclotron-based isotope production system designed to support high efficiency, large-scale and cost-effective production of commercially important medical isotopes such as zirconium-89 (89Zr), gallium-68 (68Ga), technetium‐99m (99mTc) and copper-64 (64Cu). QIS™ is used today by many of the major manufacturing networks to optimize production of a range of medical radioisotopes. ARTMS has been acquired by Telix…
Annual Revenue$10M to $25M
Estimated OwnershipBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.